Please login to the form below

Not currently logged in
Email:
Password:

teriflunomide

This page shows the latest teriflunomide news and features for those working in and with pharma, biotech and healthcare.

Sanofi licences Principia MS drug in $805m deal

Sanofi licences Principia MS drug in $805m deal

Sanofi ‘s established oral MS therapy is Aubagio (teriflunomide), which got off to a slow start after its launch in 2012 in the face of competition from rival drugs from Biogen

Latest news

More from news
Approximately 7 fully matching, plus 45 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics